Anna Frostegård

Publications
CV
Public outreach and news

Articles

Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2015;35(1):197-205
Induction of Dendritic Cell-Mediated T-Cell Activation by Modified but Not Native Low-Density Lipoprotein in Humans and Inhibition by Annexin A5 Involvement of Heat Shock Proteins
Liu A; Ming JY; Fiskesund R; Ninio E; Karabina S-A; Bergmark C; Frostegard AG; Frostegard J
Article: ATHEROSCLEROSIS. 2014;235(2):592-598
Oxidized but not native cardiolipin has pro-inflammatory effects, which are inhibited by Annexin A5
Wan M; Hua X; Su J; Thiagarajan D; Frostegard AG; Haeggstrom JZ; Frostegard J
Article: PLOS ONE. 2014;9(9):e106584
IgM-Antibodies against Phosphorylcholine in Mothers and Normal or Low Birth Weight Term Newborn Infants
Frostegard AG; Sjoberg BG; Frostegard J; Norman M
Article: PLOS ONE. 2014;9(12):e111764
Antibodies against Native and Oxidized Cardiolipin and Phosphatidylserine and Phosphorylcholine in Atherosclerosis Development
Frostegard AG; Su J; Hua X; Vikstrom M; de Faire U; Frostegard J
Article: JOURNAL OF RHEUMATOLOGY. 2013;40(11):1856-1864
Low Levels of Antibodies Against Oxidized but not Nonoxidized Cardiolipin and Phosphatidylserine Are Associated with Atherosclerotic Plaques in Systemic Lupus Erythematosus
Su J; Frostegard AG; Hua X; Gustafsson T; Jogestrand T; Hafstrom I; Frostegard J
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2013;174(3):441-448
Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality
Frostegard AG; Hua X; Su J; Carrero JJ; Heimburger O; Barany P; Stenvinkel P; Frostegard J
Article: PROSTAGLANDINS AND OTHER LIPID MEDIATORS. 2013;106:72-78
Annexin A5 inhibits atherogenic and pro-inflammatory effects of lysophosphatidylcholine
Domeij H; Hua X; Su J; Backlund A; Yan Z; Frostegard AG; Haeggstrom JZ; Modeer T; Frostegard J
Article: JOURNAL OF AUTOIMMUNITY. 2010;34(2):73-79
Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: Effects on uptake of oxidized LDL in macrophages as a potential mechanism
de Faire U; Su J; Hua X; Frostegard A; Halldin M; Hellenius M-L; Wikstrom M; Dahlbom I; Gronlund H; Frostegard J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2010;39(1):77-83
Effects of anti-cardiolipin antibodies and IVIg on annexin A5 binding to endothelial cells: implications for cardiovascular disease
Frostegard AG; Su J; von Landenberg P; Frostegard J
Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2008;37(5):352-359
Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus
Svenungsson E; Cederholm A; Jensen-Urstad K; Fei G-Z; de Faire U; Frostegard J
Article: RHEUMATOLOGY. 2008;47(8):1144-1150
Natural antibodies against phosphorylcholine as potential protective factors in SLE
Su J; Hua X; Concha H; Svenungsson E; Cederholm A; Frostegard J
Article: DRUG NEWS AND PERSPECTIVES. 2007;20(5):321-326
Annexin a5 multitasking: A potentially novel antiatherothrombotic agent?
Cederhohn A; Frostegard J
Article: ARTERIOSCLEROSIS, THROMBOSIS, AND VASCULAR BIOLOGY. 2005;25(1):198-203
Decreased binding of annexin V to endothelial cells -: A potential mechanism in atherothrombosis of patients with systemic lupus erythematosus
Cederholm A; Svenungsson E; Jensen-Urstad K; Trollmo C; Ulfgren AK; Swedenborg J; Fei GZ; Frostegård J
Article: ARTHRITIS & RHEUMATOLOGY. 2004;50(9):2869-2876
Platelet-activating factor-acetylhydrolase and other novel risk and protective factors for cardiovascular disease in systemic lupus erythematosus
Cederholm A; Svenungsson E; Stengel D; Fei GZ; Pockley AG; Ninio E; Frostegård J

All other publications

Published conference paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2007;1108:96-103
Annexin A5 as a novel player in prevention of atherothrombosis in SLE and in the general population
Cederholm A; Frostegard J
Meeting abstract: ATHEROSCLEROSIS SUPPLEMENTS. 2006;7(3):29
Decreased annexin A5 binding to endothelium is associated with cardiovascular disease in systemic lupus erythematosus and inhibited by IVIG
Cederholm A; Von Landenberg P; Frostegard J
Published conference paper: IMMUNOBIOLOGY. 2005;210(10):761-768
Annexin A5 in cardiovascular disease and systemic lupus erythematosus
Cederholm A; Frostegård J

Employments

Affiliated to Research, Institute of Environmental Medicine, Karolinska Institutet, 2024-2025

Degrees and Education

Doctor Of Philosophy, Department of Medicine, Huddinge, Karolinska Institutet, 2006

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI